Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Bioactive Membrane Immobilized with Lactoferrin for Modulation of Bone Regeneration and Inflammation.

Lee J., Lee J., Lee S., Ahmad T., Madhurakkat Perikamana SK., Kim EM.

Animal Study on Chronic Inflammation, published in Tissue Eng Part A (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Tissue Eng Part A (2020)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
32324097
DOI
10.1089/ten.tea.2020.0015
Citations
18

Abstract (original English)

Guided bone regeneration refers to the process in which bone defects could be regenerated by facilitated healing through the use of membranes, potentially with the delivery of osteoinductive molecules, however, the regeneration often failed due to inflammation during bone formation. In this study, we developed a membrane immobilized with lactoferrin to modulate both bone regeneration and inflammatory responses. Lactoferrin was immobilized on electrospun nanofibers (LF50) by exploiting an adhesive polydopamine coating method. When human adipose-derived stem cells (hADSCs) were seeded onto the nanofibers, the LF50 significantly increased the osteogenic differentiation. For example, the gene expression of osteopontin was 6.9 ± 2.3 times greater in the cells on LF50 than the cells on unmodified nanofibers without lactoferrin. In addition, the gene expression of tumor necrosis factor-alpha ( TNF-α ) of the macrophage cell line (RAW264.7) cultured on the LF50 was 0.3 ± 0.1 times reduced, indicating the lactoferrin was able to reduce inflammatory response. With implantation of nanofibers on in vivo mouse calvarial defects, the LF50 resulted in 60.9% ± 4.5% of new bone formation, which was six times greater than the results of other groups. Furthermore, when the fibers were implanted onto the in vivo mouse subcutaneous model challenged with lipopolysaccharide and interferon-γ, the area

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsBone RegenerationCell DifferentiationGuided Tissue RegenerationInflammationLactoferrinMiceNanofibersOsteogenesisRAW 264.7 Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research